TEAS Plus New Application

NUVTEYMA

Insmed Incorporated

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 98107947
Filing Date: 07/29/2023

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\981\079\98107947\xml1 \ FTK0002.JPG
*SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT NUVTEYMA
*COLOR MARK NO
*COLOR(S) CLAIMED
(If applicable)
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of NUVTEYMA followed by a design of overlapping spherical triangles.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 590 x 252
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Insmed Incorporated
*MAILING ADDRESS 700 Route 202/206
*CITY Bridgewater
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
08807
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Virginia
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Peter J. Willsey
ATTORNEY DOCKET NUMBER 35555/296
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Brown Rudnick LLP
STREET 601 Thirteenth Street NW Suite 600
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20005
PHONE 202-536-1751
FAX 617-289-0851
EMAIL ADDRESS trademarks@brownrudnick.com
OTHER APPOINTED ATTORNEY Vincent J. Badolato, Daniel J. Healy, Katherine C. Dearing, Jason M. Sobel, Ian G. DiBernardo, Scott M. Smedresman, Merri C. Moken, Morgan Jones, Alvin B. Carter III and Stephanie P. Calnan
CORRESPONDENCE INFORMATION
NAME Peter J. Willsey
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@brownrudnick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) pwillsey@brownrudnick.com; doakes@brownrudnick.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Joshua Marcus/
* SIGNATORY'S NAME Joshua Marcus, Ph.D.
* SIGNATORY'S POSITION VP, Chief IP Counsel
SIGNATORY'S PHONE NUMBER 732-487-7349
* DATE SIGNED 07/28/2023
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 98107947
Filing Date: 07/29/2023

To the Commissioner for Trademarks:

MARK: NUVTEYMA (stylized and/or with design, see mark)
The literal element of the mark consists of NUVTEYMA. The mark consists of NUVTEYMA followed by a design of overlapping spherical triangles.
The applicant, Insmed Incorporated, a corporation of Virginia, having an address of
      700 Route 202/206
      Bridgewater, New Jersey 08807
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).




The owner's/holder's proposed attorney information: Peter J. Willsey. Other appointed attorneys are Vincent J. Badolato, Daniel J. Healy, Katherine C. Dearing, Jason M. Sobel, Ian G. DiBernardo, Scott M. Smedresman, Merri C. Moken, Morgan Jones, Alvin B. Carter III and Stephanie P. Calnan. Peter J. Willsey of Brown Rudnick LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      601 Thirteenth Street NW Suite 600
      Washington, District of Columbia 20005
      United States
      202-536-1751(phone)
      617-289-0851(fax)
      trademarks@brownrudnick.com
The docket/reference number is 35555/296.
Peter J. Willsey submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Peter J. Willsey
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@brownrudnick.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): pwillsey@brownrudnick.com; doakes@brownrudnick.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Joshua Marcus/   Date: 07/28/2023
Signatory's Name: Joshua Marcus, Ph.D.
Signatory's Position: VP, Chief IP Counsel
Signatory's Phone Number: 732-487-7349
Signature method: Sent to third party for signature
Payment Sale Number: 98107947
Payment Accounting Date: 07/31/2023

Serial Number: 98107947
Internet Transmission Date: Sat Jul 29 11:06:23 ET 2023
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XXX-202307291106235
81658-98107947-860987aae6f6fac5ce846c127
9b71b84bf282260dd111ef2b636b577d65d828bd
-DA-06235400-20230728172529887977

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed